Programme CC2 Children’s interstitial lung disease


Source: International Congress 2016 – CC2 Children’s interstitial lung disease
Session: CC2 Children’s interstitial lung disease
Session type: Challenging clinical cases
Number: 83001
Disease area: Paediatric lung diseases

PDF journal article, handout or slides

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Programme CC2 Children’s interstitial lung disease. International Congress 2016 – CC2 Children’s interstitial lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Reading list CC2 Children’s interstitial lung disease
Source: International Congress 2016 – CC2 Children’s interstitial lung disease
Year: 2016

Childhood interstitial lung disease: A diagnostic challenge
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

ChILD – Children's interstitial lung disease
Source: Breathe, 14 (4) 349; 10.1183/20734735.ELF144
Year: 2018



Disease pathology in interstitial lung disease
Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options
Year: 2021


Clues in interstitial lung disease in children (chILD)
Source: International Congress 2016 – Paediatric bronchology II
Year: 2016

Clinical study of pediatric interstitial lung diseases in China
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013


Paediatric interstitial lung disease
Source: Eur Respir Mon; 2009: 46: 319–354
Year: 2009

Paediatric interstitial lung disease
Source: ERS Course 2016
Year: 2016




Clinical features of four children with pulmonary alveolar proteinosis
Source: International Congress 2014 – ILDs 5
Year: 2014


Beneficial effect of azithromycin in children with diffuse parenchymal lung disease
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014


Chronic lung disease in two patients with new integrin alfa3 gene mutations
Source: International Congress 2016 – Orphan diseases II
Year: 2016


Mindfulness-based stress reduction in patients with interstitial lung disease: A pilot study
Source: International Congress 2014 – ILDs 3
Year: 2014

Mutation alone does not predict the clinical course of surfactant protein C deficiency in children
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

Live patient and partner survey on pulmonary fibrosis
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

Lymphangioleiomyomatosis in TOSCA - TuberOus SClerosis registry to increAse disease awareness
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

Pregnancy course in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014


Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch
Source: International Congress 2014 – ILDs 2
Year: 2014

Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

The effect of pirfenidone with patients with idiopathic pulmonary fibrosis in one university hospital
Source: International Congress 2014 – ILDs 4
Year: 2014